Agritech Molecular farming company Moolec Science completed a merger with a special purpose acquisition company (SPAC) on December 30, 2022. The Luxembourg company began trading Tuesday January 3, 2003 on the NASDAQ under the symbol MLEC. Moolec Science Ltd. and LightJump Acquisition Corporation closed their business combination agreement which saw Moolec UK and LightJump become wholly owned subsidiaries of Moolec Science SA. Moolec uses genetically modified plants to produce proteins that are found in animals. The deal values Moolec at $504 million.
Moolec Science describes itself as a category creator in the alternative protein ecosystem using Molecular Farming, a disruptive technology producing animal proteins within plants. Moolec Science is a science-based ingredient company focused on producing animal proteins in plans through molecular farming.
Molecular Trading Volatility
On January 3, 2023, Moolec Science’s ordinary shares and warrants began trading on the Nasdaq Capital Market under the ticker symbols “MLEC” and “MLECW”, respectively.
With thin volumes at the start of the year and an overseas listed stock price movement has been extreme. Additionally, there were few IPOs in the last quarter. Given this scenario price was able to move excessively, shares reached an intraday high on its first day of $11.59 and closed at $9.10. The stock continued to lose ground on Wednesday and Thursday.
On Friday January 6 traded down to $4.35, volume entered the stock and with multiple halts it soared to a high of $22.20. The stock closed Friday $19.25+13.88 (+258.47%) but was last seen at $13.82 -5.43 (-28.21%) in after hours: that day Jan 6, 2023 07:59PM EST. Volatility reining supreme.
Moolec Science Overview
Moolec was spun off of Argentina’s Bioceres Crop Solutions in 2020 to commercialize the technology of using bioengineered plants to produce animal proteins. Important to not for those investing its products have not hit the market yet, but Moolec anticipates being a leader in this growing space.
Moolec has created two products so far:
- Chymosin, which is a protein used in cheesemaking that it produced in safflower;
- Gamma-linoleic acid, a nutritional oil.
The timeline in the investor presentation targets commercial release of these 2 existing products in 2025.The company is scaling these up and is working toward a diverse portfolio with over 20 patents globally.
Given this and the history of SPAC one has to wonder how long before it goes to the markets for more money.
Moolec has positioned as a B2B provider of ingredients for and from molecular farming. The purpose is to replace proteins derived from animals and to improve alternative protein products. In their investor presentation, Moolec sees a total addressable market of $65 billion.
The company also is working on two meat protein products: POORK+ and BEEF+.
- POORK+ adds pork protein to soy plants
- BEEF+ adds beef protein to pea plants.
The company says these can be used as enhancements to meat analogs and is targeting commercial launches in the next five years, according to the presentation.
Moolec’s innovation starts at the beginning of the food value chain
Pursuant to the transactions contemplated by the business combination agreement, Moolec UK and LightJump became wholly-owned subsidiaries of Moolec Science SA, a Luxembourg company incorporated for the purposes of the business combination (“Moolec Science”).
“We are very proud of our team for listing Moolec in one of the most prestigious tech exchanges without neglecting our science and operations. Moolec will become the first Molecular Farming Food-Tech company trading in public markets, which further highlights our category creator status. This is a step closer towards building a more resilient and sustainable food system, using science in food to set up a better future,” said Gastón Paladini, Chief Executive Officer, Director, and Co-Founder of Moolec Science.
The Company will ring the closing bell at Nasdaq in New York City on January 17, 2023, to celebrate the commencement of trading.
About Moolec Science SA
Moolec Science is a science-based ingredient company focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company’s technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones.
Moolec Science’s technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The company’s product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybeans and peas and Moolec Science has a growing international patent portfolio (22, both granted and pending) for its Molecular Farming technology. The company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit Source: moolecscience.com.
From The TradersCommunity News Desk